These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 22172033

  • 1. Epigenetic regulation of osteoclast differentiation.
    Yasui T, Hirose J, Aburatani H, Tanaka S.
    Ann N Y Acad Sci; 2011 Dec; 1240():7-13. PubMed ID: 22172033
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
    Takatsuna H, Asagiri M, Kubota T, Oka K, Osada T, Sugiyama C, Saito H, Aoki K, Ohya K, Takayanagi H, Umezawa K.
    J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
    [Abstract] [Full Text] [Related]

  • 8. [Epigenetic regulation of osteoclastogenesis by histone modification].
    Omata Y, Tanaka S.
    Clin Calcium; 2012 May; 22(5):619-28. PubMed ID: 22549185
    [Abstract] [Full Text] [Related]

  • 9. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P, Tu Q, Chen J.
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation.
    Song I, Kim JH, Kim K, Jin HM, Youn BU, Kim N.
    FEBS Lett; 2009 Jul 21; 583(14):2435-40. PubMed ID: 19576893
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANKL-induced c-Fos and NFATc1 expression.
    Kwak HB, Lee BK, Oh J, Yeon JT, Choi SW, Cho HJ, Lee MS, Kim JJ, Bae JM, Kim SH, Kim HS.
    Bone; 2010 Mar 21; 46(3):724-31. PubMed ID: 19900598
    [Abstract] [Full Text] [Related]

  • 17. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K, Kudo A.
    J Bone Miner Res; 2005 May 21; 20(5):840-7. PubMed ID: 15824857
    [Abstract] [Full Text] [Related]

  • 18. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH, Jin H, Shim HE, Kim HN, Ha H, Lee ZH.
    Mol Pharmacol; 2010 Jan 21; 77(1):17-25. PubMed ID: 19828731
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.